Table 2.
Enhancement patterns
| Reader 1 | Reader 2 | Kappa value | |||||
|---|---|---|---|---|---|---|---|
| PDAC | MFP | NET | PDAC | MFP | NET | ||
| Arterial phase | 0.75 | ||||||
| Hypervascular | 3(2/64) | 0(0/10) | 73(8/11) | 3(2/64) | 0(0/10) | 64(7/11) | |
| Isovascular | 10(7/64) | 100(10/10) | 27(3/11) | 14(9/64) | 90(9/10) | 36(4/11) | |
| Hypovascular | 86(55/64) | 0(0/10) | 0(0/11) | 83(53/64) | 10(1/10) | 0(0/11) | |
| Venous phase | 0.72 | ||||||
| Hypervascular | 2(1/64) | 0(0/10) | 64(7/11) | 2(1/64) | 0(0/10) | 64(7/11) | |
| Isovascular | 2(1/64) | 90(9/10) | 36(4/11) | 6(4/64) | 80(8/10) | 27(3/11) | |
| Hypovascular | 97(62/64) | 10(1/10) | 0(0/11) | 83(53/64) | 20(2/10) | 9(1/11) | |
| Vessel location | 0.85 | ||||||
| Peritumoral | 52(33/64) | 0(0/10) | 0(0/11) | 52(33/64) | 0(0/10) | 0(0/11) | |
| Intratumoral | 48(31/64) | 100(10/10) | 100(11/11) | 48(31/64) | 100(10/10) | 100(11/11) | |
| Vessel form | 0.65 | ||||||
| Fine | 16(10/64) | 70(7/10) | 0(0/11) | 16(10/64) | 90(9/10) | 0(0/11) | |
| Irregular | 84(54/64) | 30(3/10) | 100(11/11) | 84(54/64) | 10(1/10) | 100(11/11) | |
Data are percentages; data in parentheses are numbers of the solid pancreatic lesions
PDAC pancreatic ductal adenocarcinoma, MFP mass-forming pancreatitis, NET neuroendocrine tumor